Collectively, these results support a model in which ATP5IF1 overexpression compromises AML cell viability in response to stress, highlighting matrix ATP consumption as a cancer cell–specific bioenergetic vulnerability, particularly relevant in the context of BCL-2-targeted chemotherapy (Fig. 7L). This evidence concerns the gene ATP5IF1 and acute myeloid leukemia.